Yongzheng Pharmaceutical

Shanghai Yongzheng Pharmaceutical Technology Co., Ltd. is one of the earliest established clinical contract research organizations (CROs) in China, and is a CRO specializing in providing comprehensive clinical services for pharmaceutical product R&D. Yongzheng is a CRO company with 14 years of stable operation. Its headquarters is located in Shanghai, with two subsidiaries, "Chengdu Bujin" and "Beijing Hepurun", providing SMO and data management and biostatistics services respectively. Yongzheng covers more than 80% of China's regions, with service outlets established in major cities including Shanghai, Beijing, Wuxi, Tianjin, Harbin, Changchun, Shenyang, Guangzhou, Nanning, and Chengdu. The technical team of over 200 professionals all have medical or pharmaceutical backgrounds, and 60% of core members have worked for multinational companies, with rich experience in clinical research of drugs and medical devices. Yongzheng has successively undertaken hundreds of phase I to IV and post-marketing re-evaluation clinical trial projects. Over ten years of experience accumulation have enabled Yongzheng to gain rich experience in multiple therapeutic areas.

Yongzheng concentrates resources on developing its main businesses such as trial management, data management and biostatistics, pharmacovigilance, and also develops related businesses such as registration and medical affairs, and SMO, making it a CRO that can provide comprehensive services. Yongzheng possesses CTMS and eTMF systems, and the informatized and process-oriented management of clinical trials enables whole-process monitoring of project progress, quality, and cost.

Based on the business philosophy of "professional services, pragmatic win-win", Yongzheng has specially set up a "customer service center" to quickly respond to customer feedback and allocate resources in a timely manner, improving problem-solving efficiency and enhancing customer satisfaction, achieving the service quality of "quality first, efficiency prioritized".